MPR Weekly Dose Podcast #126

Emergency use authorization for intradermal administration of Jynneos; treatment approved for endometriosis pain; Amazon among the companies to receive a FDA Warning Letter for selling unapproved drugs; a diabetes drug is found to contain a possible carcinogen; and a new scale that measures peripheral impedance and pulse rate.

MPR Weekly Dose Podcast #125

A neurostimulation device has been cleared for post-C-section pain; a new plaque psoriasis treatment; the FDA addresses the contrast agent shortage; Lucentis biosimilar treatment is approved; and the recall is expanded for an over-the-counter laxative.

MPR Weekly Dose Podcast #124

Emergency Use authorization for Novavax vaccine; the Pfizer-BioNTech vaccine gains adolescent approval; submission for oral contraceptive to be switched to over the counter; Astepro nasal spray gets over-the-counter approval; and Dupixent shows benefits in pediatric patients with eosinophilic esophagitis.

MPR Weekly Dose Podcast #121

Skyrizi gains new approval; the USPSTF make recommendations on multivitamin use to prevent CVD and cancer; an FDA Panel vote on pimavanserin efficacy for treating hallucinations associated with Alzheimer disease psychosis; Phexxi analysed in over 1000 patients; and Vaxneuvance approved for some pediatrics.

MPR Weekly Dose Podcast Episode 112

A second booster dose for some COVID-19 vaccines is authorized; Sotrovimab has its use limited due to the BA.2 Omicron subvariant; An investigational oral antiviral gains Fast Track designation; PreHevbrio hepatitis B vaccine now available; And the FDA update a safety communication regard the risk of thyroid dysfunction in infants following the use of contrast…